RESEARCH PAPER
Effect of type 2 diabetes on the left ventricular diastolic dysfunction in patients with chronic kidney disease, 3 and 4 stages
 
More details
Hide details
1
Department of Internal Diseases, Gastroenterology and Hepatology, University Clinical Hospital in Olsztyn, Poland
2
Department of Internal Diseases, Gastroenterology, Cardiology and Infectiology, University of Warmia and Mazury in Olsztyn, Poland
3
Department of Internal Medicine and Cardiology, Medical University of Warsaw, Poland
CORRESPONDING AUTHOR
Leszek Gromadziński   

Department of Internal Diseases, Gastroenterology and Hepatology, University Clinical Hospital in Olsztyn, Warszawska 30, 10-082 Olsztyn, Poland. Tel.: +48 89 524 53 89; fax: +48 89 524 53 89.
Submission date: 2014-02-14
Acceptance date: 2014-04-09
Online publication date: 2014-05-15
Publication date: 2020-03-26
 
Pol. Ann. Med. 2014;21(1):8–13
KEYWORDS
ABSTRACT
Introduction:
Patients with chronic kidney disease (CKD) and coexisting diabetes mellitus (DM) are likely to have cardiological complications.

Aim:
We assessed whether patients with moderate kidney dysfunction, with coexisting type 2 DM and preserved left ventricular (LV) systolic function, demonstrate a more advanced LV diastolic dysfunction.

Material and methods:
The study group consisted of 58 ambulatory patients with CKD, stages 3 and 4. The patients were assigned to groups based on the presence of type 2 DM. The first group (DM+) consisted of 21 patients with type 2 DM while second one (DM–) consisted of 37 patients without type 2 DM. Standard echocardiography was performed in all patients with tissue Doppler echocardiography for evaluation of the systolic velocity and both diastolic velocities of LV. The following laboratory parameters were measured: serum creatinine concentration, estimated glomerular filtration rate, and the levels of urea, phosphorus, calcium, parathormone, platelets count, hemoglobin level and N-terminal pro-B-type natri-uretic peptide levels. LV diastolic dysfunction was defined as EmLV less than 8 cm/s.

Results and discussion:
Patients in DM+ group, as compared to patients in DM– group, were characterized by higher values of left and right ventricular end-diastolic dimension, left atrial diastolic dimension, interventricular septal diastolic diameter, LV posterior wall dimension at diastole and of LV mass index, smaller LV ejection fraction and LV fractional shortening. In tissue Doppler echocardiography patients of DM+ group, as compared to patients of DM– group, did not differ in value of EmLV (7.4 ± 2.4 cm/s vs. 7.6 ± 2.1 cm/s, P = .723), respectively, and were characterized by similar estimated LV diastolic filling pressure as indicated by E/EmLV (10.1 ± 3.7 vs. 8.8 ± 2.6, P = .119).

Conclusions:
CKD patients in the moderate stage, with coexisting type 2 DM were not characterized by higher risk of developing LV diastolic dysfunction.

ACKNOWLEDGEMENTS
The authors of this manuscript declare that they have complied with the Principles of Ethical Publishing present in the Declaration of Helsinki and that the study protocol was approved by a local ethics committee.
CONFLICT OF INTEREST
There are no financial or other relationship considerations that could lead to any conflict of interest.
 
REFERENCES (31)
1.
London GM. Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial. 2003;16(2):85–94.
 
2.
London GM, Parfrey PS. Cardiac disease in chronic uremia: pathogenesis. Adv Ren Replace Ther. 1997;4(3):194–211.
 
3.
Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16:489–495. http://dx.doi.org/10.1681/ASN.....
 
4.
Foley RN, Parfrey PS, Sarnak MJ. Epidermiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998;9(suppl 12):S16–S23.
 
5.
Nakai S, Suzuki K, Masakane I, et al. Overview of regular dialysis treatment in Japan. Ther Apher Dial. 2010;14:505–540. http://dx.doi.org/10.1111/j.17....
 
6.
Poirier P, Bogaty P, Garneau C, et al. Diastolic dysfunction in normotensive men with well controlled type 2 diabetes mellitus: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care. 2001;24(1):5–10.
 
7.
Hayat SA, Patel B, Khattar RS, et al. Diabetic cardiomyopathy: mechanisms, diagnosis, and treatment. Clin Sci. 2004;107(6):539–557.
 
8.
Martins D, Ani C, Pan D, et al. Renal dysfunction, metabolic syndrome and cardiovascular disease mortality. J Nutr Metab. 2010. http://dx.doi.org/10.1155/2010....
 
9.
Mano Y, Anzai T, Kaneko H, et al. Overexpression of human C-reactive protein exacerbates left ventricular remodeling in diabetic cardiomyopathy. Circ J. 2011; 75(7):1717–1727.
 
10.
Roderick PJ, Atkins RJ, Smeeth L, et al. CKD and mortality risk in older people: a community-based population study in the United Kingdom. Am J Kidney Dis. 2009;53(6):950–960. http://dx.doi.org/10.1053/j.aj....
 
11.
Waldum B, Westheim AS, Sandvik L, et al. Renal function in outpatients with chronic heart failure. J Card Fail. 2010;16(1):374–380. http://dx.doi.org/10.1016/j.ca....
 
12.
Diamant M, Lamb HJ, Groeneveld Y, et al. Diastolic dysfunction in associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol. 2003;42(2):328–335.
 
13.
Fang ZY, Prins JB, Marvick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev. 2004;25(4):543–567.
 
14.
van Heerebeek L, Hamdani N, Handoko ML, et al. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation. 2008;117(1):43–51.
 
15.
Zarich SW, Arbuckle BE, Cohen LR, et al. Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. J Am Coll Cardiol. 1998;12(1):114–120.
 
16.
Hsiao AH, Chiou KR, Lin KL, et al. Left atrial distensibility and E/e0 for estimating left ventricular filling pressure in patients with stable angina. A comparative echocardiography and characterization study. Circ J. 2011;75(8):1942–1980.
 
17.
Hung KC, Huang HL, Chu CM, et al. Evaluating preload dependence of a novel Doppler application in assessment of left ventricular diastolic function during hemodialysis. Am J Kidney Dis. 2004;43(6):1040–1046.
 
18.
Lee CH, Hung KC, Chang SH, et al. Reversible left ventricular diastolic dysfunction on Doppler tissue imaging predicts a more favourable prognosis in chronic heart failure. Circ J. 2012;76(5):1145–1150.
 
19.
Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation. 2001;102(15):1788–1794.
 
20.
Fang ZY, Yuda S, Anderson V, et al. Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol. 2003;41:611–617.
 
21.
Hayashi SY, Brodin LA, Alvestrand A, et al. Improvement of cardiac function after haemodialysis: quantitative evaluation by colour tissue velocity imaging. Nephrol Dial Transplant. 2004;19(6):1497–1506.
 
22.
Hung KC, Lee CH, Chen CC, et al. Advanced left ventricular diastolic dysfunction in uremic patients with type 2 diabetes on maintenance hemodialysis. Circ J. 2012;76:2380–2385.
 
23.
Tomaszuk-Kazberuk A, Małyszko J, Bachorzewska-Gajewska H, et al. Left ventricular morphology and function in diabetic and nondiabetic hemodialyzed patients. Hemodial Int. 2012;16(2):259–265.
 
24.
Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251–259. http://dx.doi.org/10.1056/NEJM....
 
25.
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 suppl 1):S46–S47.
 
26.
Lang RM, Bierig M, Devereux RB, et al. Recommendations of chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440–1463.
 
27.
Devereux RB, Alonso D, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy, comparison to necropsy findings. Am J Cardiol. 1986;57(6):450–455.
 
28.
Isaaz K, Thompson A, Ethevenot G, et al. Doppler echocardiographic measurement of low velocity motion of the left ventricular posterior wall. Am J Cardiol. 1989;64:66–75.
 
29.
Garcia MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol. 1998;32(4):865–875.
 
30.
Nardi E, Palermo A, Mulè G, et al. Impact of type 2 diabetes on left ventricular geometry and diastolic function in hypertensive patients with chronic kidney disease. J Hum Hypertens. 2011;25:144–151. http://dx.doi.org/10.1038/jhh.....
 
31.
Fang ZY, Najos-Valencia O, Leano R, et al. Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine. J Am Coll Cardiol. 2003;42(3):446–453.